First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer
by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris
Updated on: February 01,2024
15
First-line ribociclib and endocrine therapy may be more effective than combined chemotherapy in aggressive breast cancer
by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor-positive, HER2-negative, advanced breast cancer—including patients with visceral cris
Updated on:February 01,2024
15
